6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.

Research output: Contribution to conferencePoster

Original languageEnglish (Ireland)
Publication statusPublished - 2005

Cite this